In an effort to enhance the scientific input and expand safety in the drug development process, Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) is pleased to welcome its 19th pharmaceutical industry member, Otsuka Pharmaceutical Development & Commercialization, Inc. Otsuka brings a team of expert scientists to contribute to the projects within PSTC Working Groups.”
